Jul 07, 2026
1:3
For every 3 shares held, investors received 1. The price per share adjusted from $2.97 to $8.91.
The split itself did not change the total investment value.
COSCIENS Biopharma Inc. (NEO:CSCI) operates in the Pharmaceuticals: major industry.
COSCIENS Biopharma Inc. company overviewCOSCIENS Biopharma Inc.'s most recent stock split was on July 7, 2026. It was a 1-for-3 reverse split, so shareholders received 1 share for every 3 they held.
COSCIENS Biopharma Inc. (NEO:CSCI) has split its stock 5 times: a 1-for-6 reverse split on October 5, 2012, a 1-for-100 reverse split on November 20, 2015, a 1-for-25 reverse split on July 21, 2022, a 1-for-4 reverse split on May 6, 2024, and a 1-for-3 reverse split on July 7, 2026.
COSCIENS Biopharma Inc. has split its stock 5 times. This history records 5 reverse splits between October 5, 2012 and July 7, 2026.
A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In COSCIENS Biopharma Inc.'s 1-for-3 reverse split on July 7, 2026, every 3 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.
COSCIENS Biopharma Inc. has not announced a new split in our records. Its most recent split was on July 7, 2026, less than a year ago. Companies announce splits in advance, and any new NEO:CSCI split will appear on this page.
Already premium?